1. Home
  2. TBBK vs AMRX Comparison

TBBK vs AMRX Comparison

Compare TBBK & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBBK
  • AMRX
  • Stock Information
  • Founded
  • TBBK 1999
  • AMRX 2002
  • Country
  • TBBK United States
  • AMRX United States
  • Employees
  • TBBK N/A
  • AMRX N/A
  • Industry
  • TBBK Major Banks
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TBBK Finance
  • AMRX Health Care
  • Exchange
  • TBBK Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • TBBK 3.5B
  • AMRX 3.3B
  • IPO Year
  • TBBK 2004
  • AMRX N/A
  • Fundamental
  • Price
  • TBBK $76.31
  • AMRX $10.10
  • Analyst Decision
  • TBBK Buy
  • AMRX Strong Buy
  • Analyst Count
  • TBBK 4
  • AMRX 4
  • Target Price
  • TBBK $68.00
  • AMRX $12.00
  • AVG Volume (30 Days)
  • TBBK 577.1K
  • AMRX 1.7M
  • Earning Date
  • TBBK 10-23-2025
  • AMRX 10-30-2025
  • Dividend Yield
  • TBBK N/A
  • AMRX N/A
  • EPS Growth
  • TBBK 21.62
  • AMRX N/A
  • EPS
  • TBBK 4.65
  • AMRX 0.01
  • Revenue
  • TBBK $515,889,000.00
  • AMRX $2,852,914,000.00
  • Revenue This Year
  • TBBK N/A
  • AMRX $9.52
  • Revenue Next Year
  • TBBK $7.02
  • AMRX $6.31
  • P/E Ratio
  • TBBK $16.53
  • AMRX $965.99
  • Revenue Growth
  • TBBK 11.18
  • AMRX 9.81
  • 52 Week Low
  • TBBK $40.51
  • AMRX $6.69
  • 52 Week High
  • TBBK $80.76
  • AMRX $10.68
  • Technical
  • Relative Strength Index (RSI)
  • TBBK 56.85
  • AMRX 53.93
  • Support Level
  • TBBK $71.31
  • AMRX $10.35
  • Resistance Level
  • TBBK $79.37
  • AMRX $10.61
  • Average True Range (ATR)
  • TBBK 2.33
  • AMRX 0.29
  • MACD
  • TBBK -0.46
  • AMRX 0.00
  • Stochastic Oscillator
  • TBBK 54.81
  • AMRX 50.00

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: